Skip to content

HANCOUR PHARMASERVICE

Active Risk: not assessed
Private limited companyfounded 2008active for 18 yearsMarie Curiesquare 30, 1070 Anderlecht, BelgiumKBO/BCE: BE 0806.261.921
Summary

HANCOUR PHARMASERVICE is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €681,051 and a net result of €82,022. Equity has been growing by about 12% per year since 2018. Its solvency ranks better than 63% of 6,692 sector peers (NACE 64, financial year 2025). The company has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
HANCOUR PHARMASERVICEActive
Risk analysis ReportCompare

Overview

Official details

Source: KBO
Status
Active since 03-09-2008 Normal situation
Registered office
15 active companies are registered at this address Source: KBO register, as of 2 November 2026.
Activity
Activities of holding companies NACE 64210
Establishment unit
2.293.367.733 2640 Mortsel, since 04-02-2019
Financial year end
31 December
Peppol
Reachable
Company details

Board and ownership

Board
Auditor
KPMG Réviseurs d'Entreprises
Holdings
Shares in 1 company APOTEEK HANCOUR
Board & ownership

Financial position

Financial institution: outside the modelBankruptcy probability: sector outside the model
Annual accounts 2025
Profit
€82,022
▲ 54.0%
Equity
€681,051
▲ 13.7%
Total assets
€1.0m
▼ 1.2%
Financials
SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-03-2026, 140 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
140 days early
2024
48 days early
2023
29 days early
2022
18 days late
2021
16 days early
2020
24 days early
2019
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 37 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (4 of the last 5 accounts filed within 46 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Board changedlatest change 27-10-2026 · 1 in office 1 joined · 2 left View
  • Positive: 6 profitable years in a rowprofit 2025: €82,022 6 years View

Recent changes

  1. · Gazette deed Resignations: Wendy HANDIG (director) and Benedikte COURTIN (director)Appointments: Geert REYNIERS (sole director) and KPMG Bedrijfsrevisoren BV (statutory auditor) · Permanent representative: Axel Jorion
  2. · Gazette deed Registered office moved from Mortsel to Anderlecht
  3. · Gazette deed Changes of role: Handig Wendy (director) and Courtin Benedikte (director)
All 18 events

Comparable companies

These companies have the same main activity as HANCOUR PHARMASERVICE: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €822,000 and €1.6m, founded between 2006 and 2011.

CompanyTotal assetsGross margin
HANCOUR PHARMASERVICE Anderlecht€1.0m€0.01m
B.C. SERVICES Beveren-Kruibeke-Zwijndrecht€0.9m€0.02m
WOUTERS - LOWEL Hasselt€0.9m€0.02m
FAVERO Wevelgem€0.8m€0.02m
M. DE WIT BELGIUM Hoogstraten€1.0m€0.02m
LCY Services Genk€0.9m€0.02m
HOLDING VAN LAECKE HILDE Zedelgem€1.6m€0.02m
Full comparison

Key facts about HANCOUR PHARMASERVICE
What is the company number of HANCOUR PHARMASERVICE?
The company number of HANCOUR PHARMASERVICE is 0806.261.921. The VAT number is the same number with BE in front: BE 0806.261.921.
Where is HANCOUR PHARMASERVICE based?
The registered office is at Marie Curiesquare 30, 1070 Anderlecht.Company details
What does HANCOUR PHARMASERVICE do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of HANCOUR PHARMASERVICE?
The legal form of HANCOUR PHARMASERVICE is Private limited company (BV).
When was HANCOUR PHARMASERVICE founded?
HANCOUR PHARMASERVICE was founded on 03-09-2008.
Is HANCOUR PHARMASERVICE still active?
Yes, HANCOUR PHARMASERVICE is an active enterprise in the KBO register.
What is the turnover of HANCOUR PHARMASERVICE?
The turnover in financial year 2025 is ≈ €64,000. This figure is estimated from the gross margin of €13,093 and 54 comparable companies (NACE 64210). It probably lies between €32,000 and €110,000. It is a rough estimate.Financials
Is HANCOUR PHARMASERVICE profitable?
In financial year 2025, HANCOUR PHARMASERVICE made a profit of €82,022.
Where can I find the annual accounts of HANCOUR PHARMASERVICE?
HANCOUR PHARMASERVICE filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HANCOUR PHARMASERVICE due?
HANCOUR PHARMASERVICE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure